SCHEMBL22728320

SCHEMBL22728320

CCC(C#N)(CC)Cc1ccc2ccccc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.52
▸ CYP2A6 P11509 1/20 0.52
▸ BCHE P06276 3/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ PYCR1 P32322 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.39
▸ CASR P41180 3/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ CTSK P43235 1/20 0.38
▸ ATM Q13315 1/20 0.37
▸ SLC13A5 Q86YT5 1/20 0.36
▸ OPRL1 P41146 1/20 0.36
▸ MC4R P32245 1/20 0.36
▸ MC5R P33032 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23734246 0.75 CYP1A2 (0.59) CYP1A2CYP2A6BCHEHTR2AHTR2C
SCHEMBL22728363 0.75 RIPK1 (0.40) CYP1A2CYP2D6ATM
SCHEMBL22728398 0.73 PNMT (0.43) PYCR1ATM
SCHEMBL27962086 0.73 CYP1A2 (0.55) CYP1A2CYP2A6HTR2AHTR2CHTR2B
SCHEMBL19341333 0.72 CYP2A6 (0.59) CYP1A2CYP2A6HTR2AHTR2CHTR2B
SCHEMBL22728291 0.72 LMNA (0.37) PYCR1
SCHEMBL22728328 0.71 HTR2A (0.47) HTR2AHTR2CHTR2BSIGMAR1SLC6A4
SCHEMBL10931487 0.71 CYP1A2 (0.41) CYP1A2CYP2A6BCHEHTR2AHTR2C
SCHEMBL10914831 0.71 HRH3 (0.38) CYP1A2CYP2A6HTR2AHTR2CHTR2B
Ammonia Solution, Strong SCHEMBL27962083 0.71 CYP2A6 (0.57) CYP1A2CYP2A6HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 — — WO disclosed
Send feedback